|
Cyprotex PLC - Comparative Business Analysis Snapshot
Business Description
Cyprotex PLC. The Group's principal activity is providing vitro and in silico ADME/PK (Absorption, Distribution, Metabolism, Excretion, Toxity/Pharmacokinetic) information to the pharmaceutical industry. The Group provides technology and information to evaluate and optimize the pharmacokinetic properties of potential drugs early in the drug discovery process. Products include Cloe Screen and Cloe PK. The Cloe Screen provides information on the absorption, distribution, metabolism,excretion, toxicity and chemical properties of pharmaceutical compounds. The Cloe PK enables drug discovery scientist to predict the level and duration of a drug in the body.
Competitor Analysis
This analysis compares Cyprotex PLC with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
